NYSE: ABTAbbott Laboratories Stock Ownership
Insider buying vs selling
Have Abbott Laboratories insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jared Watkin | SENIOR VICE PRESIDENT | 2021-04-30 | 68,000 | $59.94 | $4.08MBuy |
| Jared Watkin | SENIOR VICE PRESIDENT | 2021-04-30 | 17,043 | $44.40 | $756.71kBuy |
| Jared Watkin | SENIOR VICE PRESIDENT | 2021-04-30 | 9,533 | $120.02 | $1.14MSell |
| Jared Watkin | SENIOR VICE PRESIDENT | 2021-04-30 | 85,043 | $119.89 | $10.20MSell |
| Sammy Karam | SENIOR VICE PRESIDENT | 2021-04-27 | 8,600 | $122.00 | $1.05MSell |
| Roger Bird | SENIOR VICE PRESIDENT | 2021-04-27 | 9,439 | $122.00 | $1.15MSell |
| Sammy Karam | SENIOR VICE PRESIDENT | 2021-04-27 | 8,600 | $75.90 | $652.74kBuy |
| Christopher J. Scoggins | SENIOR VICE PRESIDENT | 2021-04-01 | 1,223 | $119.84 | $146.56kSell |
| Randel William Woodgrift | SENIOR VICE PRESIDENT | 2021-04-01 | 1,368 | $119.84 | $163.94kSell |
| Andrea F. Wainer | EXECUTIVE VICE PRESIDENT | 2021-03-03 | 6,200 | $121.79 | $755.10kSell |
ABT insiders have sold more ABT shares than they have bought in the last year
Ownership
ABT Shareholders
What type of owners hold Abbott Laboratories stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 8.31% | 147,272,920 | $17.49B | Institution |
| Blackrock Inc | 7.53% | 133,426,810 | $15.85B | Institution |
| Capital Research Global Investors | 4.88% | 86,394,199 | $10.26B | Institution |
| State Street Corp | 4.03% | 71,331,163 | $8.47B | Institution |
| Capital International Investors | 3.03% | 53,591,471 | $6.37B | Institution |
| Wellington Management Group Llp | 1.76% | 31,182,319 | $3.70B | Institution |
| Massachusetts Financial Services Co | 1.53% | 27,096,608 | $3.22B | Institution |
| Morgan Stanley | 1.51% | 26,687,412 | $3.17B | Institution |
| Northern Trust Corp | 1.49% | 26,424,385 | $3.14B | Institution |
| Geode Capital Management LLC | 1.45% | 25,640,847 | $3.05B | Institution |
Abbott Laboratories Stock Ownership FAQ
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.